In this study, the authors conducted an in-depth analysis of the health status of patients enrolled in the TRISCEND II pivotal trial (Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device) to help quantify the benefit of intervention for these patients.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Tricuspid valve disease
December 12, 2024
December 12, 2024
In the TRISCEND II trial, a total of 400 patients with severe symptomatic tricuspid regurgitation were randomized in a 2:1 ratio to undergo either transcatheter tricuspid valve replacement with medical therapy (valve-replacement group) or medical therapy alone (control group).
December 6, 2024
At the International Society for Minimally Invasive Cardiothoracic Surgery Annual Scientific Meeting 2024, Tomas Holubec presented “Minimally Invasive Aortic Root and Aortic Arch Surgery.” In his presentation, he discussed the challenges and relationship between the aorta and sternum, and aortic valve and aortic root replacement.
November 26, 2024
In this article, the authors detail the seven pillars for successful management of tricuspid valve endocarditis. Surgical indications for tricuspid valve endocarditis include heart failure, uncontrolled infection, and septic emboli risk.
September 30, 2024
Dr. Gaudiani performs a full sternotomy, valve replacement, and right atrial reduction in a 55-year-old patient who has complications from a prior open pulmonary valvotomy.
September 23, 2024
This video demonstrates a patient with a failed MitraClip placement on the tricuspid valve, which led to severe tricuspid regurgitation, heart failure, and a dilated mitral annulus that required repair. The procedure included the removal of the MitraClip and the placement of an Abbott valve in the tricuspid position.
August 28, 2024
The video demonstrates a successful tricuspid valve repair using autologous pericardium to address severe tricuspid regurgitation caused by a large mass on the valve. The surgery resulted in only trivial regurgitation post-repair.
February 28, 2024
Recurrent tricuspid valve endocarditis is a difficult problem that is not uncommon. This video demonstrates how it can be solved with a CorMatrix graft.
January 10, 2024
This is a report on the first dedicated minimally invasive right atrial retractor for tricuspid valve surgery.
December 15, 2023
CTSNet is excited to announce the winner of the 2023 Innovation Video Competition, Prof. Amhad Ali Amirghofran. His submission, “Tricuspid Valve Replacement with the Right Atrial Appendage Valve: The First Report,” he demonstrates how his team’s experience with the use of the right atrial appendage for pulmonary valve position led them to design a technique to use the RAA valve for tricuspid valve replacement.